TTRX vs TYRA

Turn Therapeutics Inc. vs Tyra Biosciences, Inc. — Valuation Comparison 2026

TTRX

Biotechnology
Turn Therapeutics Inc.
Quality
4.2
out of 10
Value Trap
Price
$5.31
Last close
Models
8/13
Active
VS

TYRA

Biotechnology
Tyra Biosciences, Inc.
Quality
4.3
out of 10
Value Trap
18
SAFE
Price
$32.68
Last close
Models
7/13
Active

Model-by-Model Comparison

ModelType TTRX Fair ValueTTRX Upside TYRA Fair ValueTYRA Upside
Bayesian DCF Intrinsic $1.52 -71.5% $9.52 -70.9%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $0.13 -97.5% $5.32 -83.7%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
RCMH-DCF Intrinsic $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for TTRX vs TYRA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

TTRX vs TYRA — Which Stock Is More Undervalued?

TYRA scores higher with a 4.3/10 quality rating vs TTRX's 4.2/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Turn Therapeutics Inc. (TTRX) and Tyra Biosciences, Inc. (TYRA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

TTRX currently trades at $5.31 with a QOC of 4.2/10, while TYRA trades at $32.68 with a QOC of 4.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).